Loading…
Sectoral / Thematic · UTI Mutual Fund · AMFI code 100806UTI - Healthcare Fund
Disclosed for 95 months, Jul 2017 to Sep 2026.
Portfolio value
₹382 Cr
down ₹9.7 Cr vs Jun 2019
- Stocks held
- 23
- unchanged
- Top 10 weight
- 70.4%
- of the portfolio in its ten largest
UTI - Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In July 2019 it disclosed 23 stocks worth ₹382 Cr, down ₹9.7 Cr from Jun 2019. Its largest positions were Sun Pharmaceutical Industries Limited (11.4%), Divi's Laboratories Limited (9.4%), Dr. Reddy's Laboratories Limited (9.1%); the ten largest together made up 70.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 89.4% of its equity. Cash and debt stood at 3.0%. Compared with Jun 2019 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
6%
Holds more stocks than 6% of peers
Cash
43%
Holds more cash than 43% of peers
What these mean: concentration · cash
Holdings in July 2019
Download CSVEvery line the fund disclosed, with the change against Jun 2019. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 11.43% | up 0.96 pts | ₹43.6 Cr | up ₹2.6 Cr | Added |
| Divi's Laboratories Limited | 9.43% | up 0.44 pts | ₹36 Cr | up ₹81 L | Added |
| Dr. Reddy's Laboratories Limited | 9.09% | up 4.22 pts | ₹34.7 Cr | up ₹15.6 Cr | Added |
| Lupin Limited | 8.63% | down 0.64 pts | ₹32.9 Cr | down ₹3.3 Cr | Trimmed |
| Cipla Limited | 7.51% | down 0.27 pts | ₹28.7 Cr | down ₹1.8 Cr | Trimmed |
| IPCA Laboratories Limited | 7.27% | down 0.52 pts | ₹27.8 Cr | down ₹2.7 Cr | Trimmed |
| Zydus Lifesciences Limited | 6.08% | down 0.21 pts | ₹23.2 Cr | down ₹1.4 Cr | Trimmed |
| Sanofi India Limited | 4.86% | down 0.23 pts | ₹18.5 Cr | down ₹1.4 Cr | Trimmed |
| Torrent Pharmaceuticals Limited | 3.26% | up 0.32 pts | ₹12.4 Cr | up ₹92 L | Added |
| Cash, TREPS & receivables | 2.98% | up 0.12 pts | ₹11.4 Cr | up ₹18 L | Added |
| Natco Pharma Limited | 2.88% | down 0.04 pts | ₹11 Cr | down ₹42 L | Trimmed |
| FDC Limited | 2.85% | down 1.28 pts | ₹10.9 Cr | down ₹5.3 Cr | Trimmed |
| Pfizer Limited | 2.72% | down 2.14 pts | ₹10.4 Cr | down ₹8.7 Cr | Trimmed |
| Syngene International Limited | 2.62% | down 0.21 pts | ₹10 Cr | down ₹1.1 Cr | Trimmed |
| Max India Limited | 2.58% | down 0.23 pts | ₹9.8 Cr | down ₹1.2 Cr | Trimmed |
| Ajanta Pharma Limited | 2.48% | down 0.14 pts | ₹9.5 Cr | down ₹80 L | Trimmed |
| Dr. Lal Path Labs Limited | 2.43% | up 0.10 pts | ₹9.3 Cr | up ₹15 L | Added |
| Aurobindo Pharma Limited | 2.36% | down 0.09 pts | ₹9 Cr | down ₹58 L | Trimmed |
| Eris Lifesciences Limited | 2.13% | up 0.23 pts | ₹8.1 Cr | up ₹71 L | Added |
| Biocon Limited | 2.08% | down 0.16 pts | ₹7.9 Cr | down ₹84 L | Trimmed |
| Thyrocare Technologies Limited | 1.90% | down 0.08 pts | ₹7.2 Cr | down ₹50 L | Trimmed |
| Alkem Laboratories Limited | 1.18% | down 0.35 pts | ₹4.5 Cr | down ₹1.5 Cr | Trimmed |
| Metropolis Healthcare Limited | 0.72% | up 0.05 pts | ₹2.7 Cr | up ₹13 L | Added |
| Sun Pharma Advanced Research Company Limited | 0.55% | up 0.16 pts | ₹2.1 Cr | up ₹58 L | Added |
What changed, Jun 2019 to Jul 2019
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Dr. Reddy's Laboratories Limitedup ₹15.6 Cr (+4.22% pts)
- Sun Pharmaceutical Industries Limitedup ₹2.6 Cr (+0.96% pts)
- Torrent Pharmaceuticals Limitedup ₹92 L (+0.32% pts)
- Divi's Laboratories Limitedup ₹81 L (+0.44% pts)
- Eris Lifesciences Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jun 2019, the weight rose most in Pharmaceuticals & Biotechnology (+0.4 pts), and fell most in Healthcare Services (−0.4 pts).
- Pharmaceuticals & Biotechnology89.1% → 89.4%+0.4 pts
- Healthcare Services10.9% → 10.6%−0.4 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jul 2018 | Jan 2019 | Apr 2019 | Jun 2019 | Jul 2019 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 83.9% | 87.4% | 90.2% | 89.1% | 89.4% |
| Healthcare Services | 11.8% | 10.7% | 9.8% | 10.9% | 10.6% |
Allocation in Jul 2019change vs Jun 2019
- Pharmaceuticals & Biotechnology (18)89.4%▲ 0.4 pts
- Healthcare Services (5)10.6%▼ 0.4 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jul 2019
3.0%
▲ 0.1 pts vs Jun 2019
- Cash alone
- 3.0%
- cash and net receivables
- A year earlier
- 2.8%
- Jul 2018 · now ▲ 0.2 pts
- Last 12 months
- 1.8% – 4.2%
- lowest to highest · record 7.3% in Jul 2017
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.